PURPOSE: The purpose of this study was the use of animal models to demonstrate the importance of drug delivery (verteporfin) to plasma lipoproteins in order to attain efficacy of photodynamic therapy (PDT) in vivo. METHODS: Photosensitizers appropriately formulated in various vehicles such as pluronics and lipid-based systems were compared to delivery of the drug in DMSO in two in vivo systems. The first was a tumor model using male DBA/2 mice inoculated intradermally with M1 rhabdomyosarcoma cells and in the second, arthritis in the MRL -lpr mouse strain was enhanced by two intradermal injections of complete Freunds adjunct. RESULTS: Those formulations in which the drug was in a monomeric form were better able to transfer drug to lipoproteins, which in turn led to superior PDT in vivo. CONCLUSIONS: The ability to introduce drug in monomeric form into the circulation correlates well with efficacy of photosensitizer formulations in mouse arthritis and tumor models.
PURPOSE: The purpose of this study was the use of animal models to demonstrate the importance of drug delivery (verteporfin) to plasma lipoproteins in order to attain efficacy of photodynamic therapy (PDT) in vivo. METHODS: Photosensitizers appropriately formulated in various vehicles such as pluronics and lipid-based systems were compared to delivery of the drug in DMSO in two in vivo systems. The first was a tumor model using male DBA/2 mice inoculated intradermally with M1 rhabdomyosarcoma cells and in the second, arthritis in the MRL -lpr mouse strain was enhanced by two intradermal injections of complete Freunds adjunct. RESULTS: Those formulations in which the drug was in a monomeric form were better able to transfer drug to lipoproteins, which in turn led to superior PDT in vivo. CONCLUSIONS: The ability to introduce drug in monomeric form into the circulation correlates well with efficacy of photosensitizer formulations in mousearthritis and tumor models.
Authors: Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin Journal: Nanotechnol Rev Date: 2012-03 Impact factor: 7.848
Authors: S Miyazawa; K Nishida; T Komiyama; Y Nakae; K Takeda; M Yorimitsu; A Kitamura; T Kunisada; A Ohtsuka; H Inoue Journal: Rheumatol Int Date: 2005-10-12 Impact factor: 2.631
Authors: Hasmik Agadjanian; Jun Ma; Altan Rentsendorj; Vinod Valluripalli; Jae Youn Hwang; Atif Mahammed; Daniel L Farkas; Harry B Gray; Zeev Gross; Lali K Medina-Kauwe Journal: Proc Natl Acad Sci U S A Date: 2009-04-02 Impact factor: 11.205
Authors: Yanna Liu; Marcel H A M Fens; Bo Lou; Nicky C H van Kronenburg; Roel F M Maas-Bakker; Robbert J Kok; Sabrina Oliveira; Wim E Hennink; Cornelus F van Nostrum Journal: Pharmaceutics Date: 2020-04-09 Impact factor: 6.321